Inogen Inc Financials
Inogen Inc (INGN) reported $348.7M in revenue for fiscal year 2025, up 3.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Inogen’s margin repair is being driven by cost restraint, but the business still is not self-funding.
In FY2025, the company reported positive net income of$22.7M , but operating income remained-$30.2M . Free cash flow was-$13.7M while financing cash flow was$24.2M , which shows the reported profit still did not translate into cash generated by the core business.
Operating improvement looks more like cost-base repair than a demand-led step-up: SG&A fell from
Liquidity remains the company’s cushion: cash has dropped from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Inogen Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Inogen Inc has an operating margin of -8.7%, meaning the company loses $9 on every $100 of revenue. This results in a profitability score of 26/100. This is up from -12.7% the prior year.
Inogen Inc's revenue grew a modest 3.9% year-over-year to $348.7M. This slow but positive growth earns a score of 51/100.
Inogen Inc has a moderate D/E ratio of 0.55. This balance of debt and equity financing earns a leverage score of 58/100.
With a current ratio of 3.12, Inogen Inc holds $3.12 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 78/100.
Inogen Inc's operations used $11.2M of cash, and capex of $2.5M added to the outflow, for a free cash flow shortfall of $13.7M. This results in a cash flow score of 24/100.
Inogen Inc generates a 11.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is down from 20.6% the prior year.
Inogen Inc scores 1.39, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($148.6M) relative to total liabilities ($106.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Inogen Inc passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Inogen Inc used $0.49 of operating cash (-$11.2M OCF vs $22.7M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Inogen Inc generated $348.7M in revenue in fiscal year 2025. This represents an increase of 3.9% from the prior year.
Inogen Inc's EBITDA was -$9.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 55.6% from the prior year.
Inogen Inc reported $22.7M in net income in fiscal year 2025. This represents a decrease of 36.6% from the prior year.
Inogen Inc earned -$0.86 per diluted share (EPS) in fiscal year 2025. This represents an increase of 43.4% from the prior year.
Cash & Balance Sheet
Inogen Inc recorded an outflow of $13.7M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 637.9% from the prior year.
Inogen Inc held $103.7M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Inogen Inc's gross margin was 44.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.8 percentage points from the prior year.
Inogen Inc's operating margin was -8.7% in fiscal year 2025, reflecting core business profitability. This is up 4.0 percentage points from the prior year.
Inogen Inc's net profit margin was 6.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.2 percentage points from the prior year.
Inogen Inc's ROE was 11.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.8 percentage points from the prior year.
Capital Allocation
Inogen Inc invested $19.4M in research and development in fiscal year 2025. This represents a decrease of 10.2% from the prior year.
Inogen Inc invested $2.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 24.9% from the prior year.
Not reported for fiscal year 2025.
INGN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY09 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $354.3M | $348.7M+3.9% | $335.7M+6.4% | $315.7M-16.3% | $377.2M+5.4% | $358.0M+16.1% | $308.5M-14.8% | $361.9M+1.1% | $358.1M+43.6% | $249.4M+23.0% | $202.8M+27.6% | $159.0M+41.3% | $112.5M+49.2% | $75.4M+55.3% | $48.6M | N/A |
| Cost of Revenue | $167.4M | $163.8M+10.2% | $148.7M-6.3% | $158.6M-19.8% | $197.8M+22.2% | $161.8M+3.2% | $156.8M-10.9% | $176.0M+7.3% | $164.0M+48.9% | $110.2M+29.4% | $85.2M+38.3% | $61.6M+59.1% | $38.7M+59.2% | $24.3M+39.8% | $17.4M | N/A |
| Gross Profit | $157.7M | $154.3M-0.3% | $154.7M+22.1% | $126.7M-17.5% | $153.5M-13.0% | $176.5M+27.7% | $138.2M-19.6% | $171.9M-3.8% | $178.6M+47.3% | $121.2M+24.6% | $97.3M+27.6% | $76.3M+37.4% | $55.5M+42.4% | $39.0M+62.8% | $23.9M | N/A |
| R&D Expenses | $21.1M | $19.4M-10.2% | $21.6M+3.7% | $20.8M-5.0% | $21.9M+32.4% | $16.6M+17.7% | $14.1M+49.8% | $9.4M+33.7% | $7.0M+32.3% | $5.3M+3.9% | $5.1M+22.3% | $4.2M+40.4% | $3.0M+24.1% | $2.4M+6.0% | $2.3M | N/A |
| SG&A Expenses | $69.4M | $67.4M-7.2% | $72.6M-3.6% | $75.3M+71.4% | $43.9M+16.0% | $37.9M-2.0% | $38.6M+4.0% | $37.1M-2.4% | $38.0M+1.2% | $37.6M+18.2% | $31.8M+23.9% | $25.7M+43.0% | $17.9M+30.4% | $13.8M+65.9% | $8.3M | N/A |
| Operating Income | -$30.9M | -$30.2M+29.0% | -$42.5M+61.1% | -$109.4M-28.3% | -$85.2M-1022.5% | $9.2M+176.8% | -$12.0M-160.8% | $19.8M-47.8% | $37.9M+37.3% | $27.6M+20.7% | $22.9M+51.9% | $15.1M+43.2% | $10.5M+135.5% | $4.5M+438.5% | $829K | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $6K-72.7% | $22K-95.1% | $449K-20.1% | $562K+14.0% | $493K | N/A |
| Income Tax | -$710K | -$632K-7.5% | -$588K-660.0% | $105K-79.2% | $504K-96.6% | $15.0M+2630.8% | $549K-83.5% | $3.3M+129.2% | -$11.4M-231.6% | $8.7M+292.3% | $2.2M-29.8% | $3.1M-2.6% | $3.2M+114.9% | -$21.6M-120027.8% | $18K | N/A |
| Net Income | $20.9M | $22.7M-36.6% | $35.9M-65.0% | $102.4M+22.3% | $83.8M+1222.8% | $6.3M+208.6% | -$5.8M-127.8% | $20.9M-59.6% | $51.8M+146.9% | $21.0M+2.4% | $20.5M+77.1% | $11.6M+69.7% | $6.8M-73.2% | $25.4M+4409.8% | $564K | $2.6M |
| EPS (Diluted) | — | -$0.86+43.4% | -$1.52+65.6% | -$4.42-20.4% | -$3.67-1210.7% | -$0.28-3.7% | -$0.27-128.7% | $0.94-59.1% | $2.30+139.6% | $0.96-1.0% | $0.97+73.2% | $0.56+86.7% | $0.30 | $0.68+103.4% | -$19.97 | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
No annual filing on record for: FY2010, FY2011.
INGN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY09 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $298.6M+0.8% | $296.2M-9.2% | $326.2M-19.5% | $405.0M-17.3% | $489.5M+6.0% | $461.9M+3.2% | $447.3M+19.0% | $375.9M+36.7% | $275.1M+28.5% | $214.0M+32.7% | $161.3M+15.2% | $140.1M+70.0% | $82.4M | N/A | N/A |
| Current Assets | $198.3M+6.9% | $185.5M-10.4% | $207.1M-32.0% | $304.6M-7.5% | $329.2M+7.7% | $305.7M+4.6% | $292.2M-7.1% | $314.6M+37.7% | $228.5M+41.4% | $161.5M+40.7% | $114.8M+24.1% | $92.5M+181.9% | $32.8M | N/A | N/A |
| Cash & Equivalents | $103.7M-8.8% | $113.8M-9.3% | $125.5M-32.9% | $187.0M-20.6% | $235.5M+11.1% | $212.0M+7.0% | $198.0M+0.7% | $196.6M+37.6% | $143.0M+54.0% | $92.9M+40.5% | $66.1M+16.3% | $56.8M+320.4% | $13.5M-10.5% | $15.1M | N/A |
| Inventory | $26.0M+4.7% | $24.8M+13.6% | $21.8M-35.9% | $34.1M+7.0% | $31.9M+28.4% | $24.8M-30.4% | $35.7M+31.7% | $27.1M+43.7% | $18.8M+31.4% | $14.3M+65.9% | $8.6M+13.6% | $7.6M+79.3% | $4.2M | N/A | N/A |
| Accounts Receivable | $38.9M+31.5% | $29.6M-30.0% | $42.2M-32.7% | $62.7M+156.5% | $24.5M-17.7% | $29.7M-13.4% | $34.3M-7.3% | $37.0M+17.8% | $31.4M+2.0% | $30.8M+55.1% | $19.9M+2.7% | $19.3M+89.1% | $10.2M | N/A | N/A |
| Goodwill | $10.7M+13.0% | $9.5M-5.9% | $10.1M-69.4% | $32.9M-0.4% | $33.0M-0.6% | $33.2M+0.6% | $33.0M+1360.1% | $2.3M-4.5% | $2.4M | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $106.4M-13.0% | $122.3M+0.8% | $121.4M+12.8% | $107.6M-9.8% | $119.3M+6.3% | $112.2M+9.3% | $102.7M+56.9% | $65.5M+36.3% | $48.0M+50.3% | $32.0M+17.1% | $27.3M+24.4% | $21.9M-84.8% | $144.8M | N/A | N/A |
| Current Liabilities | $63.5M-17.1% | $76.7M+5.8% | $72.5M+10.9% | $65.3M+6.2% | $61.5M+8.5% | $56.7M+13.0% | $50.2M+7.7% | $46.6M+37.5% | $33.9M+48.3% | $22.8M+3.8% | $22.0M+17.5% | $18.7M-0.5% | $18.8M | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $315K0.0% | $315K-94.2% | $5.4M | N/A | N/A |
| Total Equity | $192.2M+10.6% | $173.9M-15.1% | $204.8M-31.1% | $297.4M-19.7% | $370.2M+5.9% | $349.6M+1.5% | $344.6M+11.0% | $310.4M+36.7% | $227.0M+24.7% | $182.1M+35.9% | $134.0M+13.4% | $118.2M+289.4% | -$62.4M+22.8% | -$80.8M | N/A |
| Retained Earnings | -$175.6M-14.9% | -$152.8M-30.7% | -$116.9M-706.5% | -$14.5M-120.9% | $69.3M-8.4% | $75.6M-7.2% | $81.4M+34.6% | $60.5M+600.1% | $8.6M+169.9% | -$12.4M+72.6% | -$45.1M+20.4% | -$56.7M+9.5% | -$62.6M | N/A | N/A |
No annual filing on record for: FY2010, FY2011.
INGN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY09 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.5M | -$11.2M-289.7% | $5.9M+282.9% | -$3.2M+91.4% | -$37.5M-258.8% | $23.6M-36.1% | $37.0M-8.8% | $40.6M-32.3% | $60.0M-0.9% | $60.5M+94.9% | $31.0M-18.7% | $38.2M+143.1% | $15.7M+16.6% | $13.5M+236.3% | $4.0M | N/A |
| Capital Expenditures | $2.5M | $2.5M-24.9% | $3.4M-35.6% | $5.2M+56.4% | $3.3M-39.1% | $5.5M+25.0% | $4.4M+39.5% | $3.1M-60.9% | $8.0M+176.0% | $2.9M+69.6% | $1.7M-22.2% | $2.2M+42.4% | $1.6M-48.8% | $3.0M+49.7% | $2.0M | N/A |
| Free Cash Flow | -$5.0M | -$13.7M-637.9% | $2.6M+130.2% | -$8.5M+79.3% | -$40.9M-325.2% | $18.2M-44.4% | $32.6M-12.9% | $37.5M-27.9% | $51.9M-9.8% | $57.6M+96.4% | $29.3M-18.5% | $36.0M+154.2% | $14.1M+35.5% | $10.4M+427.1% | $2.0M | N/A |
| Investing Cash Flow | -$6.7M | -$26.2M-87.5% | -$14.0M+76.4% | -$59.3M-445.3% | -$10.9M+25.7% | -$14.6M+42.9% | -$25.6M+41.8% | -$44.1M-76.5% | -$25.0M-2.2% | -$24.4M-104.8% | -$11.9M | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$7.5M | $24.2M+9025.3% | $265K-72.4% | $960K+152.6% | $380K-97.5% | $15.0M+626.0% | $2.1M-58.1% | $4.9M-73.1% | $18.3M+30.6% | $14.0M+81.5% | $7.7M | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
No annual filing on record for: FY2010, FY2011.
INGN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY09 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2%-1.8pp | 46.1%+5.9pp | 40.1%-0.6pp | 40.7%-8.6pp | 49.3%+4.5pp | 44.8%-2.7pp | 47.5%-2.4pp | 49.9%+1.3pp | 48.6%+0.6pp | 48.0%0.0pp | 48.0%-1.4pp | 49.3%-2.4pp | 51.7%+2.4pp | 49.3% | N/A |
| Operating Margin | -8.7%+4.0pp | -12.7%+22.0pp | -34.6%-12.0pp | -22.6%-25.2pp | 2.6%+6.5pp | -3.9%-9.4pp | 5.5%-5.1pp | 10.6%-0.5pp | 11.1%-0.2pp | 11.3%+1.8pp | 9.5%+0.1pp | 9.3%+3.4pp | 5.9%+4.2pp | 1.7% | N/A |
| Net Margin | 6.5%-4.2pp | 10.7%-21.8pp | 32.5%+10.3pp | 22.2%+20.4pp | 1.8%+3.7pp | -1.9%-7.7pp | 5.8%-8.7pp | 14.5%+6.1pp | 8.4%-1.7pp | 10.1%+2.8pp | 7.3%+1.2pp | 6.1%-27.6pp | 33.7%+32.6pp | 1.2% | N/A |
| Return on Equity | 11.8%-8.8pp | 20.6%-29.4pp | 50.0%+21.8pp | 28.2%+26.5pp | 1.7%+3.4pp | -1.7%-7.8pp | 6.1%-10.6pp | 16.7%+7.5pp | 9.3%-2.0pp | 11.3%+2.6pp | 8.6%+2.9pp | 5.8% | N/A | N/A | N/A |
| Return on Assets | 7.6%-4.5pp | 12.1%-19.3pp | 31.4%+10.7pp | 20.7%+19.4pp | 1.3%+2.6pp | -1.3%-5.9pp | 4.7%-9.1pp | 13.8%+6.2pp | 7.6%-2.0pp | 9.6%+2.4pp | 7.2%+2.3pp | 4.9%-26.0pp | 30.9% | N/A | N/A |
| Current Ratio | 3.12+0.7x | 2.42-0.4x | 2.86-1.8x | 4.66-0.7x | 5.350.0x | 5.39-0.4x | 5.82-0.9x | 6.750.0x | 6.74-0.3x | 7.07+1.9x | 5.22+0.3x | 4.94+3.2x | 1.74 | N/A | N/A |
| Debt-to-Equity | 0.55-0.2x | 0.70+0.1x | 0.59+0.2x | 0.360.0x | 0.320.0x | 0.320.0x | 0.30+0.1x | 0.210.0x | 0.210.0x | 0.18+0.2x | 0.000.0x | 0.00 | N/A | N/A | N/A |
| FCF Margin | -3.9%-4.7pp | 0.8%+3.4pp | -2.7%+8.1pp | -10.8%-15.9pp | 5.1%-5.5pp | 10.6%+0.2pp | 10.3%-4.1pp | 14.5%-8.6pp | 23.1%+8.6pp | 14.4%-8.2pp | 22.6%+10.0pp | 12.6%-1.3pp | 13.8%+9.8pp | 4.1% | N/A |
No annual filing on record for: FY2010, FY2011.
Similar Companies
Where Inogen Inc Ranks
Frequently Asked Questions
What is Inogen Inc's annual revenue?
Inogen Inc (INGN) reported $348.7M in total revenue for fiscal year 2025. This represents a 3.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Inogen Inc's revenue growing?
Inogen Inc (INGN) revenue grew by 3.9% year-over-year, from $335.7M to $348.7M in fiscal year 2025.
Is Inogen Inc profitable?
Yes, Inogen Inc (INGN) reported a net income of $22.7M in fiscal year 2025, with a net profit margin of 6.5%.
What is Inogen Inc's EBITDA?
Inogen Inc (INGN) had EBITDA of -$9.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Inogen Inc's gross margin?
Inogen Inc (INGN) had a gross margin of 44.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Inogen Inc's operating margin?
Inogen Inc (INGN) had an operating margin of -8.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Inogen Inc's net profit margin?
Inogen Inc (INGN) had a net profit margin of 6.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Inogen Inc's return on equity (ROE)?
Inogen Inc (INGN) has a return on equity of 11.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Inogen Inc's free cash flow?
Inogen Inc (INGN) recorded an outflow of $13.7M in free cash flow during fiscal year 2025. This represents a -637.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Inogen Inc's operating cash flow?
Inogen Inc (INGN) recorded an outflow of $11.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Inogen Inc's total assets?
Inogen Inc (INGN) had $298.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Inogen Inc's capital expenditures?
Inogen Inc (INGN) invested $2.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Inogen Inc spend on research and development?
Inogen Inc (INGN) invested $19.4M in research and development during fiscal year 2025.
What is Inogen Inc's current ratio?
Inogen Inc (INGN) had a current ratio of 3.12 as of fiscal year 2025, which is generally considered healthy.
What is Inogen Inc's debt-to-equity ratio?
Inogen Inc (INGN) had a debt-to-equity ratio of 0.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Inogen Inc's return on assets (ROA)?
Inogen Inc (INGN) had a return on assets of 7.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Inogen Inc's cash runway?
Based on fiscal year 2025 data, Inogen Inc (INGN) had $103.7M in cash against an annual operating cash burn of $11.2M. This gives an estimated cash runway of approximately 111 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Inogen Inc's Altman Z-Score?
Inogen Inc (INGN) has an Altman Z-Score of 1.39, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Inogen Inc's Piotroski F-Score?
Inogen Inc (INGN) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Inogen Inc's earnings high quality?
For every $1 of reported earnings, Inogen Inc (INGN) used $0.49 of operating cash (-$11.2M OCF vs $22.7M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Inogen Inc?
Inogen Inc (INGN) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.